Published in Gastroenterology on August 11, 2012
Once-daily budesonide MMX in active, mild-to-moderate ulcerative colitis: results from the randomised CORE II study. Gut (2013) 1.37
Budesonide MMX and mesalamine to induce remission in patients with ulcerative colitis. Gastroenterology (2013) 1.06
Treatment of IBD: where we are and where we are going. Am J Gastroenterol (2014) 1.02
Classical and recent advances in the treatment of inflammatory bowel diseases. Braz J Med Biol Res (2014) 0.88
Glucocorticosteroids in the treatment of inflammatory bowel disease and approaches to minimizing systemic activity. Therap Adv Gastroenterol (2013) 0.87
Current approaches to the management of new-onset ulcerative colitis. Clin Exp Gastroenterol (2014) 0.84
Second Korean guidelines for the management of ulcerative colitis. Intest Res (2017) 0.83
Inflammatory Bowel Disease in Children and Adolescents. JAMA Pediatr (2015) 0.83
Next-Generation Therapeutics for IBD. Curr Gastroenterol Rep (2015) 0.81
Oral prolonged release beclomethasone dipropionate and prednisone in the treatment of active ulcerative colitis: results from a double-blind, randomized, parallel group study. Am J Gastroenterol (2015) 0.80
Twice-daily Budesonide 2-mg Foam Induces Complete Mucosal Healing in Patients with Distal Ulcerative Colitis. J Crohns Colitis (2015) 0.79
Budesonide MMX for the Induction of Remission of Mild to Moderate Ulcerative Colitis: A Pooled Safety Analysis. J Crohns Colitis (2015) 0.79
Glucose intolerance and diabetes mellitus in ulcerative colitis: pathogenetic and therapeutic implications. World J Gastroenterol (2014) 0.78
The use of glucocorticoids in marmoset wasting syndrome. J Med Primatol (2015) 0.78
Emerging Treatment Options in Mild to Moderate Ulcerative Colitis. Gastroenterol Hepatol (N Y) (2015) 0.77
New pharmaceuticals in inflammatory bowel disease. Prz Gastroenterol (2015) 0.77
Budesonide for the treatment of ulcerative colitis. Expert Opin Pharmacother (2016) 0.77
Budesonide Foam Has a Favorable Safety Profile for Inducing Remission in Mild-to-Moderate Ulcerative Proctitis or Proctosigmoiditis. Dig Dis Sci (2015) 0.76
Mucosal healing in inflammatory bowel disease: Maintain or de-escalate therapy. World J Gastrointest Pathophysiol (2016) 0.76
Budesonide Multi-matrix for the Treatment of Patients with Ulcerative Colitis. Dig Dis Sci (2015) 0.76
Systematic Review and Meta-analysis: Placebo Rates in Induction and Maintenance Trials of Ulcerative Colitis. J Crohns Colitis (2016) 0.76
Budesonide Extended-Release in Patients With Mild to Moderate Ulcerative Colitis. Gastroenterol Hepatol (N Y) (2015) 0.75
Effectiveness of budesonide MMX (Cortiment) for the treatment of mild-to-moderate active ulcerative colitis: study protocol for a prospective multicentre observational cohort study. BMJ Open Gastroenterol (2016) 0.75
Developments in the treatment of moderate to severe ulcerative colitis: focus on adalimumab. Ther Clin Risk Manag (2013) 0.75
Enhanced therapeutic efficacy of budesonide in experimental colitis with enzyme/pH dual-sensitive polymeric nanoparticles. Int J Nanomedicine (2015) 0.75
Reply: budesonide. Gastroenterology (2013) 0.75
Alicaforsen, an antisense inhibitor of ICAM-1, as treatment for chronic refractory pouchitis after proctocolectomy: A case series. United European Gastroenterol J (2015) 0.75
Management of ulcerative colitis in Taiwan: consensus guideline of the Taiwan Society of Inflammatory Bowel Disease. Intest Res (2017) 0.75
Acute graft-versus-host disease of the gut: considerations for the gastroenterologist. Nat Rev Gastroenterol Hepatol (2017) 0.75
MMX(®) technology and its applications in gastrointestinal diseases. Therap Adv Gastroenterol (2017) 0.75
A genome-wide association study for celiac disease identifies risk variants in the region harboring IL2 and IL21. Nat Genet (2007) 8.50
Localization of a type 1 diabetes locus in the IL2RA/CD25 region by use of tag single-nucleotide polymorphisms. Am J Hum Genet (2005) 4.36
The second European evidence-based Consensus on the diagnosis and management of Crohn's disease: Definitions and diagnosis. J Crohns Colitis (2010) 3.97
Second European evidence-based consensus on the diagnosis and management of ulcerative colitis part 2: current management. J Crohns Colitis (2012) 3.69
The second European evidence-based Consensus on the diagnosis and management of Crohn's disease: Special situations. J Crohns Colitis (2009) 3.66
Guidelines on the diagnosis and management of iron deficiency and anemia in inflammatory bowel diseases. Inflamm Bowel Dis (2007) 2.89
Inter-rater reliability of nursing home quality indicators in the U.S. BMC Health Serv Res (2003) 2.83
The London Position Statement of the World Congress of Gastroenterology on Biological Therapy for IBD with the European Crohn's and Colitis Organization: when to start, when to stop, which drug to choose, and how to predict response? Am J Gastroenterol (2010) 2.74
Second European evidence-based consensus on the diagnosis and management of ulcerative colitis part 1: definitions and diagnosis. J Crohns Colitis (2012) 2.55
A continuous-wave Raman silicon laser. Nature (2005) 2.53
First-line erlotinib in patients with advanced non-small-cell lung cancer unsuitable for chemotherapy (TOPICAL): a double-blind, placebo-controlled, phase 3 trial. Lancet Oncol (2012) 2.33
Development of the Crohn's disease digestive damage score, the Lémann score. Inflamm Bowel Dis (2010) 2.20
A high-speed silicon optical modulator based on a metal-oxide-semiconductor capacitor. Nature (2004) 2.17
The ACTIVE cognitive training trial and health-related quality of life: protection that lasts for 5 years. J Gerontol A Biol Sci Med Sci (2006) 1.79
Home care quality indicators (HCQIs) based on the MDS-HC. Gerontologist (2004) 1.75
Second European evidence-based consensus on the diagnosis and management of ulcerative colitis part 3: special situations. J Crohns Colitis (2012) 1.71
Outcomes of commercial renal transplantation: a Canadian experience. Transplantation (2006) 1.71
The effects of the ACTIVE cognitive training trial on clinically relevant declines in health-related quality of life. J Gerontol B Psychol Sci Soc Sci (2006) 1.69
The Haematological Malignancy Research Network (HMRN): a new information strategy for population based epidemiology and health service research. Br J Haematol (2009) 1.67
Identification of p18 INK4c as a tumor suppressor gene in glioblastoma multiforme. Cancer Res (2008) 1.65
American gastroenterological association consensus development conference on the use of biologics in the treatment of inflammatory bowel disease, June 21-23, 2006. Gastroenterology (2007) 1.60
Serum polybrominated diphenyl ether (PBDE) levels are higher in children (2-5 years of age) than in infants and adults. Environ Health Perspect (2009) 1.60
5-aminosalicylic acids and the risk of renal disease: a large British epidemiologic study. Gastroenterology (2004) 1.57
Identification of two novel loci for dominantly inherited familial amyotrophic lateral sclerosis. Am J Hum Genet (2003) 1.56
Renal diffusion and BOLD MRI in experimental diabetic nephropathy. Blood oxygen level-dependent. J Magn Reson Imaging (2003) 1.54
Conventional medical management of inflammatory bowel disease. Gastroenterology (2011) 1.53
An all-silicon Raman laser. Nature (2005) 1.53
Using a new taxonomy to combine the uncombinable: integrating results across diverse interventions. Psychol Aging (2003) 1.53
Anti-CD3 antibody visilizumab is not effective in patients with intravenous corticosteroid-refractory ulcerative colitis. Gut (2010) 1.53
Targeting of rifamycin SV to the colon for treatment of travelers' diarrhea: a randomized, double-blind, placebo-controlled phase 3 study. J Travel Med (2014) 1.49
Comparison of ultrasound and magnetic resonance urography for evaluation of contralateral kidney in patients with multicystic dysplastic kidney disease. J Urol (2011) 1.44
Genetic regulation of birth weight and fasting glucose by a common polymorphism in the islet cell promoter of the glucokinase gene. Diabetes (2005) 1.38
Once-daily budesonide MMX in active, mild-to-moderate ulcerative colitis: results from the randomised CORE II study. Gut (2013) 1.37
Recoverable cognitive dysfunction at hospital admission in older persons during acute illness. J Gen Intern Med (2006) 1.35
European evidence-based Consensus on the management of ulcerative colitis: Special situations. J Crohns Colitis (2008) 1.34
Monomeric recombinant TCR ligand reduces relapse rate and severity of experimental autoimmune encephalomyelitis in SJL/J mice through cytokine switch. J Immunol (2004) 1.30
Evaluation of prostatitis in autopsied prostates--is chronic inflammation more associated with benign prostatic hyperplasia or cancer? J Urol (2008) 1.28
Heterologous protein production in the yeast Kluyveromyces lactis. FEMS Yeast Res (2006) 1.24
Inn1 couples contraction of the actomyosin ring to membrane ingression during cytokinesis in budding yeast. Nat Cell Biol (2008) 1.21
Ciclosporin use in acute ulcerative colitis: a long-term experience. Eur J Gastroenterol Hepatol (2005) 1.16
Electrically pumped hybrid AlGaInAs-silicon evanescent laser. Opt Express (2006) 1.15
K562/GM-CSF immunotherapy reduces tumor burden in chronic myeloid leukemia patients with residual disease on imatinib mesylate. Clin Cancer Res (2010) 1.15
Endpoints for clinical trials evaluating disease modification and structural damage in adults with Crohn's disease. Inflamm Bowel Dis (2009) 1.14
NBA1/MERIT40 and BRE interaction is required for the integrity of two distinct deubiquitinating enzyme BRCC36-containing complexes. J Biol Chem (2011) 1.14
An important role for CDK2 in G1 to S checkpoint activation and DNA damage response in human embryonic stem cells. Stem Cells (2011) 1.09
Isolated soy protein consumption reduces urinary albumin excretion and improves the serum lipid profile in men with type 2 diabetes mellitus and nephropathy. J Nutr (2004) 1.09
Incidence and clinical significance of immunogenicity to infliximab in Crohn's disease: a critical systematic review. Inflamm Bowel Dis (2009) 1.07
Red cell transfusion for the management of upper gastrointestinal haemorrhage. Cochrane Database Syst Rev (2010) 1.05
Transglutaminase inhibition reduces fibrosis and preserves function in experimental chronic kidney disease. J Am Soc Nephrol (2007) 1.05
Saturation biopsies on autopsied prostates for detecting and characterizing prostate cancer. BJU Int (2008) 1.04
Individual characteristics associated with PBDE levels in U.S. human milk samples. Environ Health Perspect (2010) 1.03
A genomic and proteomic investigation of the impact of preimplantation factor on human decidual cells. Am J Obstet Gynecol (2010) 1.03
Opposing influences of prenatal and postnatal weight gain on adrenarche in normal boys and girls. J Clin Endocrinol Metab (2004) 1.02
The effects of body mass index on cerebral blood flow velocity. Clin Auton Res (2008) 1.01
Myelin oligodendrocyte glycoprotein-35-55 peptide induces severe chronic experimental autoimmune encephalomyelitis in HLA-DR2-transgenic mice. Eur J Immunol (2004) 0.99
The inclusion of a business management module within the master of pharmacy degree: a route to asset enrichment? Pharm Pract (Granada) (2013) 0.99
Cross-regulation between Egr-1 and APE/Ref-1 during early response to oxidative stress in the human osteoblastic HOBIT cell line: evidence for an autoregulatory loop. Free Radic Res (2005) 0.98
Conserved and non-conserved features of HIV-1 and SIVagm Vif mediated suppression of APOBEC3 cytidine deaminases. Cell Microbiol (2008) 0.97
Development of the Paris definition of early Crohn's disease for disease-modification trials: results of an international expert opinion process. Am J Gastroenterol (2012) 0.97
Spatial hearing disability after acoustic neuroma removal. Laryngoscope (2007) 0.95
The Indiana Alzheimer Disease Center's Symposium on Mild Cognitive Impairment. Cognitive training in older adults: lessons from the ACTIVE Study. Curr Alzheimer Res (2009) 0.95
Why carry out a longitudinal birth survey? Paediatr Perinat Epidemiol (2009) 0.94
A botulinum toxin-derived targeted secretion inhibitor downregulates the GH/IGF1 axis. J Clin Invest (2012) 0.94
Extracellular ATP stimulates the early growth response protein 1 (Egr-1) via a protein kinase C-dependent pathway in the human osteoblastic HOBIT cell line. Biochem J (2003) 0.93
Release of 5-aminosalicylate from an MMX mesalamine tablet during transit through a simulated gastrointestinal tract system. Adv Ther (2007) 0.93
Mild traumatic brain injury and fatigue: a prospective longitudinal study. Brain Inj (2010) 0.92
Anticonvulsant hypersensitivity syndrome: treatment with corticosteroids and intravenous immunoglobulin. South Med J (2004) 0.92
Framingham risk score and novel cardiovascular risk factors underpredict major adverse cardiac events in kidney transplant recipients. Transplantation (2011) 0.91
Maintenance treatment with azathioprine in ulcerative colitis: outcome and predictive factors after drug withdrawal. Am J Gastroenterol (2009) 0.91
Chronic melatonin therapy fails to alter amyloid burden or oxidative damage in old Tg2576 mice: implications for clinical trials. Brain Res (2005) 0.91
Collagen overglycosylation: a biochemical feature that may contribute to bone quality. Biochem Biophys Res Commun (2005) 0.90
Cross-linking of cellular proteins by tissue transglutaminase during necrotic cell death: a mechanism for maintaining tissue integrity. Biochem J (2003) 0.90
Investigational methods for peroxisomal disorders. Curr Protoc Hum Genet (2008) 0.90
Collagenous gastritis: reports and systematic review. Eur J Gastroenterol Hepatol (2009) 0.90
Transient activation of meox1 is an early component of the gene regulatory network downstream of hoxa2. Mol Cell Biol (2011) 0.90
Early observations of the effects of lateral wedge orthoses on lower limb muscle length and potential for exacerbating spasticity. Prosthet Orthot Int (2010) 0.89
Transcriptome and proteome analysis of osteocytes treated with nitrogen-containing bisphosphonates. J Proteome Res (2009) 0.88
Markers of endothelial and haemostatic function in the treatment of relapsed myeloma with the immunomodulatory agent Actimid (CC-4047) and their relationship with venous thrombosis. Eur J Haematol (2005) 0.88
South Asian ethnicity as a risk factor for major adverse cardiovascular events after renal transplantation. Clin J Am Soc Nephrol (2010) 0.88
A prospective observational study of changes in renal function and cardiovascular risk following living kidney donation. Transplantation (2008) 0.88
Evaluation of proinflammatory cytokines and inflammation markers as biomarkers for the action of thiazolidinediones in Type 2 diabetes mellitus patients and healthy volunteers. Br J Clin Pharmacol (2006) 0.88
Efficacy of intracolonic administration of low-molecular-weight heparin CB-01-05, compared to other low-molecular-weight heparins and unfractionated heparin, in experimentally induced colitis in rat. Dig Dis Sci (2008) 0.87
Metastases to breast from primary lung cancer. J Thorac Oncol (2009) 0.87
Preimplantation factor (PIF) analog prevents type I diabetes mellitus (TIDM) development by preserving pancreatic function in NOD mice. Endocrine (2011) 0.87
Stability of whole blood at -70 degrees C for measurement of hemoglobin A(1c) in healthy individuals. Clin Chem (2004) 0.87
Population-based analysis of prostate-specific antigen (PSA) screening in younger men (<55 years) in Australia. BJU Int (2013) 0.87
Quantitative nuclear magnetic resonance analysis and characterization of the derivatized Haemophilus influenzae type b polysaccharide intermediate for PedvaxHIB. Anal Biochem (2005) 0.87
The European (ECCO) Consensus on infection in IBD: what does it change for the clinician? Gut (2009) 0.87
Fatal fat embolism following an isolated vertebral fracture. Acta Orthop Belg (2007) 0.87
Genetically diverse coronaviruses in wild bird populations of northern England. Emerg Infect Dis (2009) 0.86
Renal transplant outcome in high-cardiovascular risk recipients. Clin Transplant (2007) 0.86